This website isn’t supported by Internet Explorer. We recommend that you use a different browser (e.g. Edge, Chrome, Firefox, Safari, or similar) for the best experience of our content.
Science Hub

Welcome to Novo Nordisk Science Hub

The information on this website is intended for healthcare professionals only and is provided solely for the purpose of scientific exchange. By accessing this website you accept this legal disclaimer and you expressly confirm your status as a healthcare professional.

 

This website is not country specific and may therefore contain information that is not applicable to your country. The website is not intended to provide medical advice and/or treatment guidance. Therefore, before prescribing any product, always refer to information approved by regulatory authorities in your country such as the prescribing information and/or the Summary of Product Characteristics. Novo Nordisk accepts no liability for the accuracy, completeness or use of information on this website, and disclaims any liability to update the information contained on this website.

Are you a healthcare professional?

Speaker - Rao Huiying
Rao
Huiying
Peking University Hepatology Institute, Beijing, China

Current Position, Department, Affiliation:

• Director, Peking University Hepatology Institute, Peking University People's Hospital

 

• Vice Director, Clinical Trial Center, Peking University People's Hospital

 

• Member, The Chinese Society of Hepatology

 

• Vice President, the Fatty Liver Group of the Chinese Society of Hepatology

 

• Vice President, Hepatology Society of the Beijing Medical Association

 

Areas of interest

• Non-alcoholic fatty liver disease (NAFLD)

 

• Hepatitis B and C Liver cirrhosis

 

Educational and Career Experiences:

• 2006 – current, Peking University Hepatology Institute, Peking University People’s Hospital

 

• 2006, graduated from Peking University Health Science Center

 

Honors and Awards:

• Second-class prize of Chinese Medical Science and Technology Award

properties.alt

Jacob George

University of Sydney, Sydney, Australia


Current Position, Department, Affiliation: 

• Robert W. Storr Professor of Hepatic Medicine at the Storr Liver Centre, Westmead Institute for Medical Research, University of Sydney

 

• Head of the Department of Gastroenterology and Hepatology at Westmead Hospital

 

• Director of Gastroenterology and Hepatology Services for the Western Sydney Local Health District

 

Areas of interest

• Basic and clinical research on metabolic dysfunction-associated fatty liver disease (MAFLD)

 

• Hepatitis C

 

• Liver cancer and hepatic fibrosis

 

Educational and Career Experiences:

Professor George is an Associate Editor for the Journal of Hepatology, and a senior Editor for Seminars in Liver Disease (since 2022) and Journal of Hepatology Reports. He is on the executive committee of the International Association for the study of Liver (IASL), was a past Executive Council member and Chair of Research for the Asian Pacific Association for the Study of the Liver (APASL), and previous board member of the Gastroenterological Society of Australia and previous Chair of the Liver Faculty of the Gastroenterological Society of Australia. He is the current chair of the APASL MAIDEN consortium. He has published extensively.

 

Honors and Awards:

Professor George has received the 2021 Premier's Awards for Outstanding Cancer Research, NSW Cancer Institute, 2021 Sally Crossing AM Award for Outstanding Research, Cancer Council NSW, 2020 Okuda-Omata APASL Distinguished Research, Asian Pacific Association for Study of Liver Disease (APASL), election to AAHMS (2017), Distinguished

Researcher Prize, Gastroenterological Society of Australia (2017), Westmead Millennium Institute Science Prize for outstanding research (each year for 2017–2022) and is a Clarivate highly cited researcher for 2022 and 2023.


Read full bio